The global micro pump market was valued at $1,653.7 million in 2021, and is projected to reach $7,395.5 million by 2031, registering a CAGR of 16.2% from 2022 to 2031. Micro pump is defined as a device that can control and manipulate small fluid volumes. It is a miniature fluid delivery device capable of generating flow at finite pressure loads. Micro pump contains a microfluidic system that generate flow of the fluid in the range of milliliters to microliters. Application of micro pump include drug delivery, biological detection, and cardiology system. Mechanical and non-mechanical micro pump are two subcategories of micro pump. Moving parts are present in mechanical micro pump, whereas are absent in non-mechanical micro pump. Micro pumps are also used for a variety of biomedical uses, including the transdermal delivery of insulin, artificial sphincter prostheses, blood-transporting antithrombogenic micro pump, and micro pump for the injection of glucose for diabetics.
The micro pump market is driven by increase in the awareness regarding controlled drug delivery, rise in number of in-vitro diagnostic test, rise in number of key players in field of manufacturing medical device. Moreover, micro pumps are used in controlled drug delivery in patients of chemotherapy and insulin therapy. Increase in number of chronic diseases such as cancer and diabetes, is anticipated to increase the demand of micro pump in biological application. Thus, this factor anticipated to drive the growth of micro pump market. Chemotherapy and insulin therapy use micropumps for controlled drug delivery. Thus, rise in number chronic diseases such as cancer, increase the demand for micro pump. For instance, according to World Health Organization (WHO), in 2020, approximately 2.26 million new breast cancer cases were diagnosed worldwide. Moreover, according to International Diabetes Federation (IDF), in 2021, approximately 537 million adults in the age group of 20-79 suffered from diabetes over the globe. The total number of people suffering from diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. In addition, rise in number of product launches and product approvals in the field of micro pump development is expected to drive the market growth. For instance, in November 2019, TTP Ventus Ltd., a micro pump manufacturing company, announced a launch of new micro pump such as HP Series and LT Series that deliver higher pressures, higher flow rates, and longer lifetimes for applications including medical diagnostics, microfluidics research, and therapeutic devices. This strategy helped the company to increase its sales. Moreover, numerous drug delivery application causes rise in the demand of micro pump in medical field. In addition, increase in number of research activities and rise in number of pharmaceutical and biotechnology companies further propel the demand of micro pump. Thus, these factors are anticipated to boost the growth of micro pump market. Moreover, micro pumps are also used in in-vitro diagnostic test. Furthermore, increase in number of infectious and chronic diseases cause rise in number of in-vitro diagnostic test. Thus, rise in number of in-vitro diagnostic test boosts the market growth. Moreover, rise in initiatives taken by government to develop healthcare infrastructure fuels the demand for micro pump usage in the medical industry. Thus, these factors are anticipated to fuel the growth of micro pump market.
Geriatric population is more susceptible to infectious diseases and chronic diseases. Rise geriatric population increases the demand for micro pump for infusion of controlled drug delivery. Thus, this factor contributes to drive the growth of micro pump market. In addition, Governments globally have increased the expenditure on the healthcare sector. For instance, according to the Centers for Medicare & Medicaid Services, the U.S. health care spending grew by 9.7% from 2020 to 2019, reaching $4.1 trillion ($12,530 per person). Similarly, as per the Office for National Statistics, total healthcare expenditure in the UK accounted for 12.8% of the gross domestic product (GDP) in 2020, compared to 10.2% in 2019. Furthermore, it has been estimated that approximately 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure, especially medical equipment used at public health centers (hospitals). Hence, this rise in healthcare expenditure across the globe is expected to fuel the demand for micro pump application in different disease treatments, thereby boosting the market growth.
On the other hand, the strict laws pertaining to the usage of micro pump in human healthcare and high manufacturing cost of micro pump are anticipated to restrain the growth of the micro pump market.
The global micro pump market is segmented on the basis of type, material, application, end user and region. On the basis of type, the market is segmented into mechanical and non-mechanical. Mechanical segment further sub-categorized into piezoelectric micro pump, electrostatic micro pump, and electromagnetic micro pump. On the basis of material, the market is classified into plastics & composites, ceramics, and metals. On the basis of application, the market is classified into drug delivery, in-vitro diagnosis, medical device and others. Others include cell culture, tissue culture and drug dosing. On the basis of end user, the market is divided into hospitals & diagnostic, biotechnology & pharmaceutical companies, and academic & research institutes. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global micro pump market include ALLDOO Micro pump, Arcmed (Bio-Chem Fluidics), Bartels Mikrotechnik GmbH, Bürkert GmbH & Co. KG , Cole-Parmer India Pvt, Enomoto Micro Pump Mfg. Co., Fluigent, Idex, Sandur Fluid Controls PVT.LTD, Takako Industries, Takasago Electric, Inc., TCS micro pump, The Lee Company, Thomas, TOPS Industry & Technology Co., Ltd., TTP Ventus, and Xavitech.
The micro pump market is driven by increase in the awareness regarding controlled drug delivery, rise in number of in-vitro diagnostic test, rise in number of key players in field of manufacturing medical device. Moreover, micro pumps are used in controlled drug delivery in patients of chemotherapy and insulin therapy. Increase in number of chronic diseases such as cancer and diabetes, is anticipated to increase the demand of micro pump in biological application. Thus, this factor anticipated to drive the growth of micro pump market. Chemotherapy and insulin therapy use micropumps for controlled drug delivery. Thus, rise in number chronic diseases such as cancer, increase the demand for micro pump. For instance, according to World Health Organization (WHO), in 2020, approximately 2.26 million new breast cancer cases were diagnosed worldwide. Moreover, according to International Diabetes Federation (IDF), in 2021, approximately 537 million adults in the age group of 20-79 suffered from diabetes over the globe. The total number of people suffering from diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. In addition, rise in number of product launches and product approvals in the field of micro pump development is expected to drive the market growth. For instance, in November 2019, TTP Ventus Ltd., a micro pump manufacturing company, announced a launch of new micro pump such as HP Series and LT Series that deliver higher pressures, higher flow rates, and longer lifetimes for applications including medical diagnostics, microfluidics research, and therapeutic devices. This strategy helped the company to increase its sales. Moreover, numerous drug delivery application causes rise in the demand of micro pump in medical field. In addition, increase in number of research activities and rise in number of pharmaceutical and biotechnology companies further propel the demand of micro pump. Thus, these factors are anticipated to boost the growth of micro pump market. Moreover, micro pumps are also used in in-vitro diagnostic test. Furthermore, increase in number of infectious and chronic diseases cause rise in number of in-vitro diagnostic test. Thus, rise in number of in-vitro diagnostic test boosts the market growth. Moreover, rise in initiatives taken by government to develop healthcare infrastructure fuels the demand for micro pump usage in the medical industry. Thus, these factors are anticipated to fuel the growth of micro pump market.
Geriatric population is more susceptible to infectious diseases and chronic diseases. Rise geriatric population increases the demand for micro pump for infusion of controlled drug delivery. Thus, this factor contributes to drive the growth of micro pump market. In addition, Governments globally have increased the expenditure on the healthcare sector. For instance, according to the Centers for Medicare & Medicaid Services, the U.S. health care spending grew by 9.7% from 2020 to 2019, reaching $4.1 trillion ($12,530 per person). Similarly, as per the Office for National Statistics, total healthcare expenditure in the UK accounted for 12.8% of the gross domestic product (GDP) in 2020, compared to 10.2% in 2019. Furthermore, it has been estimated that approximately 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure, especially medical equipment used at public health centers (hospitals). Hence, this rise in healthcare expenditure across the globe is expected to fuel the demand for micro pump application in different disease treatments, thereby boosting the market growth.
On the other hand, the strict laws pertaining to the usage of micro pump in human healthcare and high manufacturing cost of micro pump are anticipated to restrain the growth of the micro pump market.
The global micro pump market is segmented on the basis of type, material, application, end user and region. On the basis of type, the market is segmented into mechanical and non-mechanical. Mechanical segment further sub-categorized into piezoelectric micro pump, electrostatic micro pump, and electromagnetic micro pump. On the basis of material, the market is classified into plastics & composites, ceramics, and metals. On the basis of application, the market is classified into drug delivery, in-vitro diagnosis, medical device and others. Others include cell culture, tissue culture and drug dosing. On the basis of end user, the market is divided into hospitals & diagnostic, biotechnology & pharmaceutical companies, and academic & research institutes. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global micro pump market include ALLDOO Micro pump, Arcmed (Bio-Chem Fluidics), Bartels Mikrotechnik GmbH, Bürkert GmbH & Co. KG , Cole-Parmer India Pvt, Enomoto Micro Pump Mfg. Co., Fluigent, Idex, Sandur Fluid Controls PVT.LTD, Takako Industries, Takasago Electric, Inc., TCS micro pump, The Lee Company, Thomas, TOPS Industry & Technology Co., Ltd., TTP Ventus, and Xavitech.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the micro pump market analysis from 2021 to 2031 to identify the prevailing micro pump market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the micro pump market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global micro pump market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
- Mechanical
- Type
- Piezoelectric micropump
- Electrostatic micropump
- Electromagnetic micropump
- Non Mechanical
By Material
- Plastics and Composites
- Ceramics
- Metals
By Application
- Medical device
- Others
- Drug delivery
- In Vitro Diagnosis
By End User
- Hospitals and Diagnostic Centers
- Biotechnology and Pharmaceutical Companies
- Academic and Research Institutes
By Region
- North America
- U.S
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- ALLDOO Micropump Inc
- Arcmed Co. Ltd.
- Bartels Mikrotechnik Inc
- Burkert GmbH and Co. KG
- Cole Parmer India Pvt. Ltd.
- Enomoto Micro Pump Mfg. Co
- Fluigent Inc
- IDEX Corporation
- Sandur Fluid Controls PVT. LTD.
- Takako Industries, Inc
- Takasago Electric, Inc
- TCS Micropump Ltd
- The Lee Company, Inc.
- Thomas
- TOPS Industry and Technology Co., Ltd.
- TTP Ventus Ltd
- Xavitech Micropump AB
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: MICRO PUMP MARKET, BY TYPE
CHAPTER 5: MICRO PUMP MARKET, BY MATERIAL
CHAPTER 6: MICRO PUMP MARKET, BY APPLICATION
CHAPTER 7: MICRO PUMP MARKET, BY END USER
CHAPTER 8: MICRO PUMP MARKET, BY REGION
CHAPTER 9: COMPANY LANDSCAPE
CHAPTER 10: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report, titled, “Micro Pump Market," the micropump market size was valued at $1.65 billion in 2021, and is estimated to reach $7.40 billion by 2031, growing at a CAGR of 16.2% from 2022 to 2031. Micro pumps are instruments used in medicine to regulate and work with small quantities of fluid. Micro pumps, consist of axial and centrifugal pumps, which aim to operate on a different principle than conventional pumps since their functional dimensions are in the micrometer range. Micro pumps are utilized for a wide range of application, including fluid mixing and fluid transportation, and dispensing medication in precisely measured doses. Some of the medical uses for micro pump include blood transportation through artificial hearts, transdermal insulin delivery, hormone therapy, pain and wound care management, and injection of medicines and glucose.Factors that drive growth of the micropump market size include rise in number of key players to manufactures micro pump, rise in the research activities which enhances demand of micro pump, increase in number of pharmaceutical and biotechnology companies. For instance, some of the key micropump industry players operating in the micro pump market include TTP Ventus, Thomas (Gardner Denver), Idex, The Lee Company, Takasago Electric, Inc., Cole-Parmer India Pvt. Ltd., Dolomite Microfluidics (Blacktrace Holdings Ltd.), Bio-Chem Fluidics (Halma), and Servoflo Corporation among others. Moreover, rise in number of chronic and infectious diseases cause rise in usage of micro pump for in-vitro diagnosis. Chronic diseases such as cancer and diabetes require chemotherapy and insulin therapy respectively. In these therapies there is requirement of micro pump for controlled drug delivery which increases the demand of micro pump in medical field. Thus, this factor is anticipated to fuel the micropump market growth.
Moreover, rise in number of product launches in the field of micropump boosts the micropump market trends. For instance, in June 2019, TTP Ventus, a micro pump manufacturing company, announced the launch of its latest product line, the LT Series. The new pump products have been developed to serve applications with demanding operational life requirements across the life science, medical industrial and environmental sectors. This product launch helped the company in enhancing its overall product portfolio. In addition, rise in number of chronic diseases such as cancer causes rise in application of micro pump in medical treatment. For instance, according to National Cancer Institute, in 2020, estimated number of new cancer cases in the U.S. are 1,806,590 and estimated number of deaths are 606,520. Moreover, according to world cancer research and international, in 2020 approximately 18,094,716 new cancer cases diagnosed across the globe. As per the same source breast and lung cancers were the most common cancers worldwide, contributing 12.5% and 12.2% of the total number of new cases diagnosed in 2020.
On the basis of type, the market is classified into mechanical and non-mechanical. The mechanical segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to technological advancement in manufacturing of mechanical micro pump, availability of different micro pump and rise in use of mechanical microscope in micro-electro-mechanical systems (MEMS), which is used in drug delivery.
On the basis of material, it is classified into plastics & composites, ceramics, metals. The plastics & composites segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to increase in use of plastic & composites in mechanical micropump technological advancement in the field of healthcare sector cause rise in the demand of high-quality micro pump.
On the basis of application, the market is classified into drug delivery, in-vitro diagnosis, medical device and others. The drug delivery segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to rise in drug delivery application, increase in awareness regarding controlled drug delivery and rise in number of chronic diseases such as cancer and diabetes.
On the basis of end user, the market is classified into hospitals & diagnostic centers, biotechnology & pharmaceutical companies, academic & research institutes. The hospitals & diagnostic centers segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to rise in the number of hospitals, increase in the expenditure by government to develop healthcare infrastructure and rise in number of chronic diseases.
North America accounted for a majority of the global micropump market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to increase in the number of research activities, technological advancement in the healthcare sector and rise in the prevalence of chronic diseases. Asia-Pacific is anticipated to witness lucrative growth, owing to rise in expenditure by government organization to develop healthcare sector, increase in prevalence of chronic diseases and rise in the number of key players who manufacture micro pump.
The COVID-19 outbreak is anticipated to have a positive impact on growth of the global micropump market. Increase in the expenditure by government and private organization for treatment of COVID-19 anticipated to fuel the growth of micropump market. Micro pump has been used during Covid-19 pandemic for treatment and investigation purpose.
Key Findings of the Study
- By type, the mechanical segment was the highest contributor to the market in 2021.
- By material, the plastic & composites segment was the highest contributor to the market in 2021.
- By application, the drug delivery segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
- By end user, the hospital & diagnostic centers segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
- By region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Alldoo Micropump Inc
- Arcmed Co. Ltd.
- Bartels Mikrotechnik Inc
- Burkert GmbH and Co. Kg
- Cole Parmer India Pvt. Ltd.
- Enomoto Micro Pump Mfg. Co
- Fluigent Inc
- Idex Corporation
- Sandur Fluid Controls Pvt. Ltd.
- Takako Industries, Inc
- Takasago Electric, Inc
- Tcs Micropump Ltd
- The Lee Company, Inc.
- Thomas
- Tops Industry and Technology Co. Ltd.
- Ttp Ventus Ltd
- Xavitech Micropump Ab
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 320 |
| Published | July 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 1653.7 million |
| Forecasted Market Value ( USD | $ 7395.5 million |
| Compound Annual Growth Rate | 16.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 17 |
